1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatology Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 External Use
1.2.3 Oral
1.2.4 Injection
1.3 Market by Application
1.3.1 Global Dermatology Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Psoriasis
1.3.3 Skin Infections
1.3.4 Acne
1.3.5 Dermatitis
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Dermatology Drug Market Perspective (2016-2027)
2.2 Dermatology Drug Growth Trends by Regions
2.2.1 Dermatology Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dermatology Drug Historic Market Share by Regions (2016-2021)
2.2.3 Dermatology Drug Forecasted Market Size by Regions (2022-2027)
2.3 Dermatology Drug Industry Dynamic
2.3.1 Dermatology Drug Market Trends
2.3.2 Dermatology Drug Market Drivers
2.3.3 Dermatology Drug Market Challenges
2.3.4 Dermatology Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermatology Drug Players by Revenue
3.1.1 Global Top Dermatology Drug Players by Revenue (2016-2021)
3.1.2 Global Dermatology Drug Revenue Market Share by Players (2016-2021)
3.2 Global Dermatology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dermatology Drug Revenue
3.4 Global Dermatology Drug Market Concentration Ratio
3.4.1 Global Dermatology Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatology Drug Revenue in 2020
3.5 Dermatology Drug Key Players Head office and Area Served
3.6 Key Players Dermatology Drug Product Solution and Service
3.7 Date of Enter into Dermatology Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermatology Drug Breakdown Data by Type
4.1 Global Dermatology Drug Historic Market Size by Type (2016-2021)
4.2 Global Dermatology Drug Forecasted Market Size by Type (2022-2027)
5 Dermatology Drug Breakdown Data by Application
5.1 Global Dermatology Drug Historic Market Size by Application (2016-2021)
5.2 Global Dermatology Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Dermatology Drug Market Size (2016-2027)
6.2 North America Dermatology Drug Market Size by Type
6.2.1 North America Dermatology Drug Market Size by Type (2016-2021)
6.2.2 North America Dermatology Drug Market Size by Type (2022-2027)
6.2.3 North America Dermatology Drug Market Size by Type (2016-2027)
6.3 North America Dermatology Drug Market Size by Application
6.3.1 North America Dermatology Drug Market Size by Application (2016-2021)
6.3.2 North America Dermatology Drug Market Size by Application (2022-2027)
6.3.3 North America Dermatology Drug Market Size by Application (2016-2027)
6.4 North America Dermatology Drug Market Size by Country
6.4.1 North America Dermatology Drug Market Size by Country (2016-2021)
6.4.2 North America Dermatology Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Dermatology Drug Market Size (2016-2027)
7.2 Europe Dermatology Drug Market Size by Type
7.2.1 Europe Dermatology Drug Market Size by Type (2016-2021)
7.2.2 Europe Dermatology Drug Market Size by Type (2022-2027)
7.2.3 Europe Dermatology Drug Market Size by Type (2016-2027)
7.3 Europe Dermatology Drug Market Size by Application
7.3.1 Europe Dermatology Drug Market Size by Application (2016-2021)
7.3.2 Europe Dermatology Drug Market Size by Application (2022-2027)
7.3.3 Europe Dermatology Drug Market Size by Application (2016-2027)
7.4 Europe Dermatology Drug Market Size by Country
7.4.1 Europe Dermatology Drug Market Size by Country (2016-2021)
7.4.2 Europe Dermatology Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Dermatology Drug Market Size (2016-2027)
8.2 Asia-Pacific Dermatology Drug Market Size by Type
8.2.1 Asia-Pacific Dermatology Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dermatology Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dermatology Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Dermatology Drug Market Size by Application
8.3.1 Asia-Pacific Dermatology Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dermatology Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dermatology Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Dermatology Drug Market Size by Region
8.4.1 Asia-Pacific Dermatology Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dermatology Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Dermatology Drug Market Size (2016-2027)
9.2 Latin America Dermatology Drug Market Size by Type
9.2.1 Latin America Dermatology Drug Market Size by Type (2016-2021)
9.2.2 Latin America Dermatology Drug Market Size by Type (2022-2027)
9.2.3 Latin America Dermatology Drug Market Size by Type (2016-2027)
9.3 Latin America Dermatology Drug Market Size by Application
9.3.1 Latin America Dermatology Drug Market Size by Application (2016-2021)
9.3.2 Latin America Dermatology Drug Market Size by Application (2022-2027)
9.3.3 Latin America Dermatology Drug Market Size by Application (2016-2027)
9.4 Latin America Dermatology Drug Market Size by Country
9.4.1 Latin America Dermatology Drug Market Size by Country (2016-2021)
9.4.2 Latin America Dermatology Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dermatology Drug Market Size (2016-2027)
10.2 Middle East & Africa Dermatology Drug Market Size by Type
10.2.1 Middle East & Africa Dermatology Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dermatology Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dermatology Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Dermatology Drug Market Size by Application
10.3.1 Middle East & Africa Dermatology Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dermatology Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dermatology Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Dermatology Drug Market Size by Country
10.4.1 Middle East & Africa Dermatology Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dermatology Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Dermatology Drug Introduction
11.1.4 AbbVie Revenue in Dermatology Drug Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Dermatology Drug Introduction
11.2.4 Johnson & Johnson Revenue in Dermatology Drug Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Dermatology Drug Introduction
11.3.4 Bayer Revenue in Dermatology Drug Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 Galderma
11.4.1 Galderma Company Details
11.4.2 Galderma Business Overview
11.4.3 Galderma Dermatology Drug Introduction
11.4.4 Galderma Revenue in Dermatology Drug Business (2016-2021)
11.4.5 Galderma Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Dermatology Drug Introduction
11.5.4 Bristol-Myers Squibb Revenue in Dermatology Drug Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Dermatology Drug Introduction
11.6.4 Novartis Revenue in Dermatology Drug Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Dermatology Drug Introduction
11.7.4 Pfizer Revenue in Dermatology Drug Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Merz Pharma
11.8.1 Merz Pharma Company Details
11.8.2 Merz Pharma Business Overview
11.8.3 Merz Pharma Dermatology Drug Introduction
11.8.4 Merz Pharma Revenue in Dermatology Drug Business (2016-2021)
11.8.5 Merz Pharma Recent Development
11.9 Valeant
11.9.1 Valeant Company Details
11.9.2 Valeant Business Overview
11.9.3 Valeant Dermatology Drug Introduction
11.9.4 Valeant Revenue in Dermatology Drug Business (2016-2021)
11.9.5 Valeant Recent Development
11.10 LEO Pharma
11.10.1 LEO Pharma Company Details
11.10.2 LEO Pharma Business Overview
11.10.3 LEO Pharma Dermatology Drug Introduction
11.10.4 LEO Pharma Revenue in Dermatology Drug Business (2016-2021)
11.10.5 LEO Pharma Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Dermatology Drug Introduction
11.11.4 GlaxoSmithKline Revenue in Dermatology Drug Business (2016-2021)
11.11.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
